XML 67 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Equity-based Compensation Expense Categories In Consolidated Statements of Operations and Comprehensive Loss

The Company recorded equity-based compensation in the following expense categories in the consolidated statements of operations and comprehensive income (loss) in 2023 and 2022 (in thousands):

 

 

2023

 

 

2022

 

General and administrative

 

$

18,270

 

 

$

16,939

 

Research and development

 

 

12,168

 

 

 

11,018

 

Total equity-based compensation

 

$

30,438

 

 

$

27,957

 

Schedule of Assumptions Used to Estimate Fair value The grant date fair value was estimated at the time of grant using the Black-Scholes option-pricing model using the following weighted-average assumptions in 2023 and 2022:

 

 

2023

 

 

2022

 

Risk-free interest rate

 

 

4.0

%

 

 

2.7

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

Expected volatility

 

 

78.7

%

 

 

79.8

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Summary of Stock Options Activity

The following table summarizes 2023 and 2022 stock option activity (options and aggregate intrinsic value in thousands):

 

 

Number of Options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (in Years)

 

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2021

 

 

9,259

 

 

$

15.77

 

 

 

 

 

 

 

Granted

 

 

2,888

 

 

$

12.96

 

 

 

 

 

 

 

Exercised

 

 

(1,523

)

 

$

4.31

 

 

 

 

 

 

 

Forfeited

 

 

(1,290

)

 

$

13.80

 

 

 

 

 

 

 

Outstanding as of December 31, 2022

 

 

9,334

 

 

$

17.04

 

 

 

 

 

 

 

Granted

 

 

2,091

 

 

$

10.96

 

 

 

 

 

 

Exercised

 

 

(58

)

 

$

4.30

 

 

 

 

 

 

Forfeited

 

 

(828

)

 

$

22.63

 

 

 

 

 

 

Outstanding as of December 31, 2023

 

 

10,539

 

 

$

15.46

 

 

 

7.94

 

 

$

10,753

 

Exercisable as of December 31, 2023

 

 

5,535

 

 

$

15.37

 

 

 

7.49

 

 

$

10,170

 

Summary of Activity Related to RSUs

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value

 

Outstanding unvested as of December 31, 2021

 

 

 

 

$

 

Granted(1)

 

 

502

 

 

$

13.28

 

Vested

 

 

(46

)

 

$

13.60

 

Forfeited

 

 

(87

)

 

$

13.60

 

Outstanding unvested as of December 31, 2022

 

 

369

 

 

$

13.16

 

Granted

 

 

638

 

 

$

11.29

 

Vested

 

 

(178

)

 

$

11.90

 

Forfeited

 

 

(25

)

 

$

12.26

 

Outstanding unvested as of December 31, 2023

 

 

804

 

 

$

11.98

 

 

(1)
The number granted represents the number of shares issuable upon vesting of service-based and market-based RSUs, assuming the Company achieves its corporate stock price metrics at the target achievement level.
Summary of Activity Related to RSAs

The following table summarizes the activity related to RSAs during 2023 and 2022 (shares in thousands):

 

 

Number of Shares

 

 

Weighted-Average Grant Date Fair Value

 

Outstanding unvested as of December 31, 2021

 

 

89

 

 

$

3.87

 

Vested

 

 

(46

)

 

$

3.87

 

Forfeited

 

 

(28

)

 

$

3.87

 

Outstanding unvested as of December 31, 2022

 

 

15

 

 

$

3.87

 

Vested

 

 

(14

)

 

$

3.87

 

Forfeited

 

 

(1

)

 

$

3.87

 

Outstanding unvested as of December 31, 2023

 

 

 

 

$

 

Restricted Stock Units (RSUs) [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Assumptions Used to Estimate Fair value The following table details the assumptions used in the Monte Carlo simulation model used to estimate the fair value of the market-based RSUs granted during 2022:

 

 

2022

 

Stock price

 

$

12.98

 

Volatility

 

 

82.5

%

Expected term (in years)

 

 

2.7

 

Risk-free rate

 

 

2.9

%

Expected dividend yield

 

 

0.0

%